BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26912443)

  • 1. Interventional Molecular Imaging.
    Solomon SB; Cornelis F
    J Nucl Med; 2016 Apr; 57(4):493-6. PubMed ID: 26912443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined imaging modalities: PET/CT and SPECT/CT.
    Maurer AH
    Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is PET the future of nuclear medicine?
    Maisey M
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1045-6. PubMed ID: 12827314
    [No Abstract]   [Full Text] [Related]  

  • 4. Is PET the future of nuclear medicine?
    Bailey DL
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1047-9. PubMed ID: 12811533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nuclear Medicine in diagnosis of breast cancer].
    Iakovou IP; Giannoula E
    Hell J Nucl Med; 2014; 17(3):221-7. PubMed ID: 25397630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional positron emission tomography/computed tomography: state-of-the-art.
    Shyn PB
    Tech Vasc Interv Radiol; 2013 Sep; 16(3):182-90. PubMed ID: 23993081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
    Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
    Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET/CT in lymphoma.
    Juweid ME
    Methods Mol Biol; 2011; 727():1-19. PubMed ID: 21331925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear medicine and molecular imaging of the pediatric chest: current practical imaging assessment.
    Grant FD; Treves ST
    Radiol Clin North Am; 2011 Sep; 49(5):1025-51. PubMed ID: 21889020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion imaging in nuclear medicine--applications of dual-modality systems in oncology.
    Schillaci O; Simonetti G
    Cancer Biother Radiopharm; 2004 Feb; 19(1):1-10. PubMed ID: 15068606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research: the future of the molecular imaging technologist-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist section.
    Holbrook S; Baldwin J; Gilmore CD; Henkin R; Hubble W; Kiss C; Bires AM; Mann A; Nelson KP; Owen MA; Sobey K; Stuckey A; Wenzel-Lamb N; Wilkinson D; Wintering NA
    J Nucl Med Technol; 2014 Sep; 42(3):228-32. PubMed ID: 25125447
    [No Abstract]   [Full Text] [Related]  

  • 14. Demystifying nuclear medicine.
    Bean B
    Biomed Instrum Technol; 2009; Suppl():31-5. PubMed ID: 19891110
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
    Däbritz J; Jasper N; Loeffler M; Weckesser M; Foell D
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):81-9. PubMed ID: 21042220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
    Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
    Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nuclear medicine: current concepts.
    Noto RB; Scheiner JD
    Med Health R I; 1999 Jun; 82(6):190-4. PubMed ID: 10402834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
    Basu S; Alavi A
    J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
    [No Abstract]   [Full Text] [Related]  

  • 19. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
    Gulyás B; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.